By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure
Duke Officials Decline To Provide Details Of Probe
Biostatisticians Write To Varmus Asking NCI To Investigate
The Lancet Oncology Issues “Expression Of Concern” Over Paper
Duke Insiders Allege Intimidation By Administration
Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Galleri MCD vote: What FDA asked its advisors to ignore









